WHO ICTRP trial
Post Marketing Surveillance Study (PMS) to generate safety and efficacy data of…
CTRI/2020/06/025925 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2020/06/025925 |
|---|---|
| Public title | Post Marketing Surveillance Study (PMS) to generate safety and efficacy data of Febrex Plus Syrup |
| Scientific title | Prescriber Based, Post Marketing Surveillance Study (PMS) to generate safety and efficacy data of Febrex Plus Syrup |
| Primary sponsor | Indoco Remedies Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: R509- Fever, unspecified |
| Interventions | Intervention1: Febrex Plus Syrup: Twice Orally for three days Control Intervention1: NIL: NIL |
| Registration date | Jun 16, 2020 |
| Target size | 200 |
| Secondary IDs | Indoco/PMS/FEBREX PLUS SYRUP//102019 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: